tiprankstipranks
Trending News
More News >
iCoreConnect (ICCT)
NASDAQ:ICCT
US Market

iCoreConnect (ICCT) AI Stock Analysis

Compare
142 Followers

Top Page

IC

iCoreConnect

(NASDAQ:ICCT)

37Underperform
iCoreConnect's overall stock score is impacted significantly by the negative financial performance, including high leverage, negative margins, and reliance on external funding. Technical indicators also suggest a bearish trend, further weighing down the score. Valuation metrics do not provide any relief, as the negative P/E ratio highlights ongoing losses. The lack of positive earnings call data or corporate events leaves no immediate prospects for improvement.

iCoreConnect (ICCT) vs. S&P 500 (SPY)

iCoreConnect Business Overview & Revenue Model

Company DescriptioniCoreConnect (ICCT) is a technology company that specializes in developing secure cloud-based software solutions for the healthcare industry. The company's core products and services include electronic health records (EHR) systems, secure communication tools, and compliance software designed to enhance operational efficiency and security for healthcare providers.
How the Company Makes MoneyiCoreConnect makes money primarily through subscription-based revenue models, where healthcare providers pay recurring fees for access to its software solutions. Additional revenue streams may include implementation and training services, as well as potential partnerships with other healthcare technology providers. These partnerships can enhance the company's offerings and expand its customer base, thereby increasing revenue.

iCoreConnect Financial Statement Overview

Summary
iCoreConnect is experiencing growth in revenue, but profitability and financial stability are major concerns. The company faces operational and financial challenges, with negative margins, high leverage, and reliance on external financing. While there is revenue growth, the sustainability of operations is uncertain without significant improvements.
Income Statement
40
Negative
The company shows a consistent increase in total revenue over the years, indicating growth potential. However, the gross profit margin is declining, and the net profit margin remains negative, reflecting ongoing losses. EBIT and EBITDA margins are also negative, highlighting operational challenges. Revenue growth is positive, but profitability remains a concern.
Balance Sheet
30
Negative
The balance sheet reveals a high debt-to-equity ratio, with negative stockholders' equity, indicating potential financial instability. The equity ratio is also negative, showing a reliance on liabilities. These factors suggest significant financial risk and leverage issues.
Cash Flow
35
Negative
Operating cash flow and free cash flow are negative, indicating cash outflows from operational activities. The free cash flow to net income ratio is unfavorable due to consistent net losses. Financing cash flow is positive, suggesting reliance on external funding. Overall, cash flow management appears weak.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
11.05M8.15M7.99M4.96M2.12M1.01M
Gross Profit
7.46M6.12M5.74M3.38M1.11M709.00K
EBIT
-17.12M-10.28M-4.80M-3.29M-3.24M-3.38M
EBITDA
-22.93M-11.88M-3.51M-1.52M-2.35M-2.09M
Net Income Common Stockholders
-29.07M-15.55M-7.36M-5.80M-3.68M-3.15M
Balance SheetCash, Cash Equivalents and Short-Term Investments
6.74K1.22M196.15K71.81K7.62K445.00K
Total Assets
6.25M15.69M6.56M6.63M2.69M2.52M
Total Debt
5.48M7.88M6.71M3.96M1.58M948.00K
Net Debt
5.47M6.66M6.51M3.89M1.57M503.00K
Total Liabilities
7.34M11.24M9.06M5.63M3.32M2.06M
Stockholders Equity
-1.10M4.44M-2.50M1.01M-628.94K465.00K
Cash FlowFree Cash Flow
-9.58M-9.71M-1.57M-3.20M-1.81M-2.09M
Operating Cash Flow
-8.32M-8.82M-1.27M-2.90M-1.27M-1.67M
Investing Cash Flow
-2.13M-10.21M-293.96K-3.52M-917.90K-473.00K
Financing Cash Flow
10.20M20.06M1.69M6.48M1.75M2.58M

iCoreConnect Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.97
Price Trends
50DMA
1.76
Positive
100DMA
2.38
Positive
200DMA
6.33
Negative
Market Momentum
MACD
0.17
Negative
RSI
86.78
Negative
STOCH
66.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ICCT, the sentiment is Positive. The current price of 3.97 is above the 20-day moving average (MA) of 2.00, above the 50-day MA of 1.76, and below the 200-day MA of 6.33, indicating a neutral trend. The MACD of 0.17 indicates Negative momentum. The RSI at 86.78 is Negative, neither overbought nor oversold. The STOCH value of 66.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ICCT.

iCoreConnect Peers Comparison

Overall Rating
UnderperformOutperform
Sector (48)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$967.51M48.535.72%0.37%4.51%32.28%
48
Neutral
$6.36B1.28-45.04%2.64%19.24%1.69%
37
Underperform
$7.65M-1718.32%42.66%-98.89%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ICCT
iCoreConnect
3.97
-25.63
-86.59%
HSTM
HealthStream
31.34
6.55
26.42%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.